Bachli, Esther B <br/><br/>
Drotrecogin alfa (activated) for the treatment of meningococcal purpura fulminans.  [electronic resource] 

 -  Intensive care medicine  Feb 2003 
 - 337 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>0342-4642 
<br/><br/><label>Standard No.: </label>10.1007/s00134-002-1605-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Anti-Infective Agents--therapeutic use<br/>Anti-Inflammatory Agents, Non-Steroidal--therapeutic use<br/>Female<br/>Fibrinolytic Agents--therapeutic use<br/>Humans<br/>IgA Vasculitis--blood<br/>Inflammation<br/>Male<br/>Meningococcal Infections--blood<br/>Protein C--therapeutic use<br/>Recombinant Proteins--therapeutic use<br/>Severity of Illness Index<br/>Shock, Septic--blood<br/>Treatment Outcome